Hyperthyroidism and hypothyroidism in patients with autoimmune pancreatitis.

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS
ACS Applied Bio Materials Pub Date : 2024-12-01 Epub Date: 2024-09-26 DOI:10.1097/MEG.0000000000002846
Kenji Hirano, Katsuyuki Sanga, Hisayoshi Natomi, Kazuhiro Niwa
{"title":"Hyperthyroidism and hypothyroidism in patients with autoimmune pancreatitis.","authors":"Kenji Hirano, Katsuyuki Sanga, Hisayoshi Natomi, Kazuhiro Niwa","doi":"10.1097/MEG.0000000000002846","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The objective of this study is to clarify the clinical features of thyroid dysfunction observed in patients with autoimmune pancreatitis (AIP).</p><p><strong>Methods: </strong>We repeatedly examined thyroid function in 74 patients with type 1 AIP (58 males, 16 females; average onset age of AIP 67 years). Clinical and serological findings in patients with thyroid dysfunction were analyzed.</p><p><strong>Results: </strong>During follow-up, clinical and subclinical hypothyroidism were observed in 3 and 17 patients, respectively. Clinical and subclinical hyperthyroidism were observed in 5 and 1 patients, respectively. One patient showed clinical hyperthyroidism followed by subclinical hypothyroidism. All patients with clinical and subclinical hypothyroidism were asymptomatic and required no medical treatment, whereas four patients with clinical hyperthyroidism were symptomatic and received treatment with thiamazole.</p><p><strong>Conclusion: </strong>Frequent hypothyroidism in AIP, which was previously reported, was confirmed. Moreover, in this study, the association between hyperthyroidism and AIP was demonstrated. Hyperthyroidism in AIP may be more clinically significant than hypothyroidism because patients frequently require medical treatment.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MEG.0000000000002846","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/26 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: The objective of this study is to clarify the clinical features of thyroid dysfunction observed in patients with autoimmune pancreatitis (AIP).

Methods: We repeatedly examined thyroid function in 74 patients with type 1 AIP (58 males, 16 females; average onset age of AIP 67 years). Clinical and serological findings in patients with thyroid dysfunction were analyzed.

Results: During follow-up, clinical and subclinical hypothyroidism were observed in 3 and 17 patients, respectively. Clinical and subclinical hyperthyroidism were observed in 5 and 1 patients, respectively. One patient showed clinical hyperthyroidism followed by subclinical hypothyroidism. All patients with clinical and subclinical hypothyroidism were asymptomatic and required no medical treatment, whereas four patients with clinical hyperthyroidism were symptomatic and received treatment with thiamazole.

Conclusion: Frequent hypothyroidism in AIP, which was previously reported, was confirmed. Moreover, in this study, the association between hyperthyroidism and AIP was demonstrated. Hyperthyroidism in AIP may be more clinically significant than hypothyroidism because patients frequently require medical treatment.

自身免疫性胰腺炎患者的甲状腺功能亢进症和甲状腺功能减退症。
研究目的本研究旨在阐明自身免疫性胰腺炎(AIP)患者甲状腺功能障碍的临床特征:我们对74名1型AIP患者(58名男性,16名女性;AIP平均发病年龄67岁)的甲状腺功能进行了反复检查。结果:在随访过程中,甲状腺功能障碍患者的临床和血清学结果均有所改善:结果:在随访期间,分别有 3 名和 17 名患者出现临床和亚临床甲状腺功能减退。分别有 5 名和 1 名患者出现临床和亚临床甲状腺功能亢进。一名患者先出现临床甲亢,后出现亚临床甲减。所有临床和亚临床甲状腺功能减退症患者均无症状,无需药物治疗,而4名临床甲状腺功能亢进症患者有症状,并接受了噻马唑治疗:结论:AIP患者中经常出现甲状腺功能减退,这在之前的报道中得到了证实。此外,本研究还证实了甲状腺功能亢进症与 AIP 之间的关联。甲状腺功能亢进症在AIP中的临床意义可能大于甲状腺功能减退症,因为患者经常需要接受药物治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信